Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations
    • DIETARY SUPPLEMENTS—S.D. Cal.: Consumers could be reasonably misled by failure to disclose that 300 mg dosage required consumption of two gummies
    • BILLING AND CODING—SETTLEMENT AGREEMENTS: RegalCare and executives to pay $1M in overbilling settlement
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • CONTROLLED SUBSTANCES—NOTICES: DEA revokes methadone clinic registration over persistent compliance failures
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • ENFORCEMENT ACTIONS—NOTICES: DEA revokes Texas pharmacy registration over diversion safeguards failures
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • FALSE CLAIMS ACT—N.D. Ga.: Court grants motion to dismiss in false claims action against orthopedic surgery health practice
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • MEDICARE CONTRACTORS—PRRB DECISIONS: Medicare contractor properly calculated hospital’s allowable interest costs
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • ORGAN PROCUREMENT AND TRANSPLANTATION—OIG REPORTS: OIG audit uncovers issues with allocating costs related to transportation of organs
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • PRESCRIPTION DRUGS—FINAL RULES: CMS finalizes mandatory Medicare drug pricing model
      • You have 1 more complimentary views available this month. Log in if you are already a customer
    • REGULATION TRACKER—Information on pending or recently adopted regulations and regulation amendments
      • You have 1 more complimentary views available this month. Log in if you are already a customer
  • Articles
    • Articles
  • Law Firms
    • Law Firms
  • Organizations
    • Organizations

    Health Law Daily Wrap Up, PRESCRIPTION DRUGS—FINAL RULES: CMS finalizes mandatory Medicare drug pricing model, (Oct 5, 2026)

    By WK Editorial Staff

    CMS’s new mandatory payment model will test whether tying Medicare Part B drug pricing more closely to international benchmarks can curb high U.S. drug costs, with drug manufacturers potentially facing additional rebate obligations when prices ...

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use